Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
Sinovac Biotech announced positive top-line results from...
Sinovac Biotech, a vaccine maker headquartered in...
Simcere Pharma, like many US-listed China biopharmas, has...
Sinovac Biotech reported the Beijing Drug Administration...
BeiGene of Beijing out-licensed the ex-China rights for a...
Sinovac Biotech has submitted a Clinical Trial...
Mindray Medical acquired a controlling stake in Shanghai...
Sinovac Biotech will receive a $9.6 million government...
Chindex accepted a buy-out offer of $24 per share from...
Sinovac Biotech, a China vaccine company, licensed rights...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
